| NCT Number | NCT07689864 |
| Lead Sponsor | Yale University |
| Conditions | Molecular Residual Disease, Cancer |
| Enrollment | 2,500 participants |
| Start Date | 2026-08 |
| Primary Completion | 2031-08 (estimated) |
| Study Completion | 2031-08 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-08 |